Strategies to enhance the removal of the persistent pharmaceutically active compound carbamazepine by membrane bioreactors

Desalination and Water Treatment

Volumn 34, Issue 1-3, 2011, Pages 402-407

  Li, Xueqing ^a   Hai, Faisal Ibney ^a   Tadkaew, Nichanan ^a   Gilbertson, Sara ^a   Nghiem, Long Duc ^a  

^a UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

Carbamazepine; Dissolved oxygen; Enhanced removal; Membrane bioreactor; Pharmaceutically active compound; Wastewater

Indexed keywords

EID: 80054946100     PISSN: 19443994     EISSN: 19443986     Source Type: Journal    
DOI: 10.5004/dwt.2011.2893     Document Type: Article

References (31)

1. Ternes, T. A., 1998. Occurrence of drugs in German sewage treatment plants and rivers. Water Res., 32 (11):3245–3260.
2. Katsuki Kimura, H. H., and Watanabe, Yoshimasa. 2005. Removal of pharmaceutical compounds by submerged membrane bioreactors (MBRs). Desalination, 178 (1–3):135–140.
3. Zhang, Y., Geiben, S.-U., and Gal, C., 2008. Carbamazepine and diclofenac:Removal in wastewater treatment plants and occurrence in water bodies. Chemosphere, 73 (8):1151
4. Heberer, T., 2002. Tracking persistent pharmaceutical residues from municipal sewage to drinking water. J. Hydrol., 266 (3–4):175–189.
5. Weigel, S., Bester, K., and Hühnerfuss, H., 2001. New method for rapid solid-phase extraction of large-volume water samples and its application to non-target screening of North Sea water for organic contaminants by gas chromatography-mass spectrometry. J. Chromatogr. A, 912 (1):151–161.
6. Osenbruck, K., Glaser, H.-R., Knoller, K., Weise, S. M., Moder, M., Wennrich, R., Schirmer, M., Reinstorf, F., Busch, W., and Strauch, G., 2007. Sources and transport of selected organic micropollutants in urban groundwater underlying the city of Halle (Saale), Germany. Water Res., 41 (15):3259–3270.
7. Drewes, J. E., Heberer, T., and Reddersen, K., 2002. Fate of pharmaceuticals during indirect potable reuse. Water Sci. Technol.,:73–80.
8. Nakada, N., Shinohara, H., Murata, A., Kiri, K., Managaki, S., Sato, N., and Takada, H., 2007. Removal of selected pharmaceuticals and personal care products (PPCPs) and endocrine-disrupting chemicals (EDCs) during sand filtration and ozonation at a municipal sewage treatment plant. Water Res., 41 (19):4373–4382.
9. Clara, M., Kreuzinger, N., Strenn, B., Gans, O., and Kroiss, H., 2005. The solids retention time--a suitable design parameter to evaluate the capacity of wastewater treatment plants to remove micro-pollutants. Water Res., 39 (1):97–106.
10. Zhang, J., Chua, H. C., Zhou, J., and Fane, A. G., 2006. Factors affecting the membrane performance in submerged membrane bioreactors. J. Membr. Sci., 284 (1–2):54
11. Alturki, A. A., Tadkaew, N., McDonald, J. A., Khan, S. J., Price, W. E., and Nghiem, L. D., 2010. Combining MBR and NF/RO membrane filtration for the removal of trace organics in indirect potable water reuse applications. J.Membr. Sci., 365 (1–2):206–215.
12. Vanderford, B. J., and Snyder, S. A., 2006. Analysis of pharmaceuticals in water by isotope dilution liquid chromatography/tandem mass spectrometry. Environ. Sci. Technol., 40 (23):7312–7320.
13. Clescerl, L. S., Greenberg, A. E., and Eaton, A. D., 2005. Standard Methods for Examination of Water & Wastewater, 21st ed., American Public Health Association.
14. Löffler, D., Römbke, J., Meller, M., and Ternes, T. A., 2005. Environmental fate of pharmaceuticals in water/sediment systems. Environ. Sci. Technol., 39 (14):5209–5218.
15. Stamatelatou, K., Frouda, C., Fountoulakis, M. S., Drillia, P., Kornaros, M., and Lyberatos, G., 2003. Pharmaceuticals and health care products in wastewater effluents:the example of carbamazepine. Water Sci. Technol. Water Supply, 3:131–137.
16. Joss, A., Zabczynski, S., Göbel, A., Hoffmann, B., Löffler, D., McArdell, C. S., Ternes, T. A., Thomsen, A., and Siegrist, H., 2006. Biological degradation of pharmaceuticals in municipal wastewater treatment:Proposing a classification scheme. Water Res., 40 (8):1686
17. Kim, S. D., Cho, J., Kim, I. S., Vanderford, B. J., and Snyder, S. A., 2007. Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters. Water Res., 41 (5):1013–1021.
18. Abegglen, C., Joss, A., McArdell, C. S., Fink, G., Schlüsener, M. P., Ternes, T. A., and Siegrist, H., 2009. The fate of selected micropollutants in a single-house MBR. Water Res., 43 (7):2036–2046.
19. Radjenovic, J., Petrovic, M., and Barceló, D., 2009. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. Water Res., 43 (3):831–841.
20. Bernhard, M., Müller, J., and Knepper, T. P., 2006. Biodegradation of persistent polar pollutants in wastewater:Comparison of an optimised lab-scale membrane bioreactor and activated sludge treatment. Water Res., 40 (18):3419–3428.
21. Kreuzinger, N., Clara, M., Strenn, B., and Kroiss, H., 2004. Relevance of the sludge retention time (SRT) as design criteria for wastewater treatment plants for the removal of endocrine disruptors and pharmaceuticals from wastewater. Water Sci. Technol., 50 (5):149–156.
22. Urase, T., Kagawa, C., and Kikuta, T., 2005. Factors affecting removal of pharmaceutical substances and estrogens in membrane separation bioreactors. Desalination, 178 (1–3):107–113.
23. Tadkaew, N., Sivakumar, M., Khan, S. J., McDonald, J. A., and Nghiem, L. D., 2010. Effect of mixed liquor pH on the removal of trace organic contaminants in a membrane bioreactor. Bioresour. Technol., 101 (5):1494–1500.
24. Dosoretz, C. G., and Böddeker, K. W., 2004. Removal of trace organics from water using a pumped bed-membrane bioreactor with powdered activated carbon. J. Membr. Sci., 239 (1):81–90.
25. Kovarova-Kovar, K., and Egli, T., 1998. Growth kinetics of suspended microbial cells:From single-substrate- controlled growth to mixed-substrate kinetics. Microbiologyand Molecular Biology Reviews, 62 (3):646–666.
26. Baldwin, D. D., and Campbell, C. E., 2001. Short-term effects of low pH on the microfauna of an activated sludge wastewater treatment system. Water Qual. Res. J. Can., 36 (3):519–535.
27. Zhang, T., Liu, Y., and Fang, H. H. P., 2005. Effect of pH change on the performance and microbial community of enhanced biological phosphate removal process. Biotechnol. Bioeng., 92 (2):173–182.
28. Zwiener, C., and Frimmel, F. H., 2003. Short-term tests with a pilot sewage plant and biofilm reactors for the biological degradation of the pharmaceutical compounds clofibric acid, ibuprofen, and diclofenac. Sci. Total Environ., 309 (1–3):201–211.
29. Tran, N. H., Urase, T., and Kusakabe, O., 2009. The characteristics of enriched nitrifier culture in the degradation of selected pharmaceutically active compounds. J. Hazard. Mater., 171 (1–3):1051–1057.
30. Hai, F. I., Yamamoto, K., and Fukushi, K., 2006. Development of a submerged membrane fungi reactor for textile wastewater treatment. Desalination, 192 (1–3):315–322.
31. Hai, F. I., Yamamoto, K., Nakajima, F., and Fukushi, K., 2008. Removal of structurally different dyes in submerged membrane fungi reactor--Biosorption/PAC-adsorption, membrane retention and biodegradation. J.Membr. Sci., 325 (1):395–403.